Pharma-Bio Serv Inc
Pharma-Bio Serv, Inc. operates as a regulatory affair, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company offers a broad range of technical compliance consulting services, including regulatory affairs, quality assurance, compliance, technology transfer, validation, engineering, project management, and pr… Read more
Pharma-Bio Serv Inc (PBSV) - Total Assets
Latest total assets as of October 2025: $13.65 Million USD
Based on the latest financial reports, Pharma-Bio Serv Inc (PBSV) holds total assets worth $13.65 Million USD as of October 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Pharma-Bio Serv Inc - Total Assets Trend (2007–2025)
This chart illustrates how Pharma-Bio Serv Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Pharma-Bio Serv Inc - Asset Composition Analysis
Current Asset Composition (October 2025)
Pharma-Bio Serv Inc's total assets of $13.65 Million consist of 98.1% current assets and 2.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 24.8% |
| Accounts Receivable | $2.36 Million | 17.3% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2007–2025)
This chart illustrates how Pharma-Bio Serv Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Pharma-Bio Serv Inc's current assets represent 98.1% of total assets in 2025, an increase from 0.0% in 2007.
- Cash Position: Cash and equivalents constituted 24.8% of total assets in 2025, down from 50.1% in 2007.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 1.0% in 2007.
- Asset Diversification: The largest asset category is accounts receivable at 17.3% of total assets.
Pharma-Bio Serv Inc Competitors by Total Assets
Key competitors of Pharma-Bio Serv Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
UCrest Bhd
KLSE:0005
|
Malaysia | RM48.46 Million |
|
Vanfund Urban Investment & Development Co Ltd
SHE:000638
|
China | CN¥265.74 Million |
|
BIT Computer Co. Ltd
KQ:032850
|
Korea | ₩82.38 Billion |
|
ezCaretech Co. LTD
KQ:099750
|
Korea | ₩56.71 Billion |
|
SyntekaBio Inc
KQ:226330
|
Korea | ₩33.49 Billion |
|
Carelabs Co.Ltd
KQ:263700
|
Korea | ₩105.15 Billion |
|
Shanghai Kingstar Winning Software
SHE:300253
|
China | CN¥8.35 Billion |
|
Longmaster Information Tech
SHE:300288
|
China | CN¥1.33 Billion |
Pharma-Bio Serv Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Pharma-Bio Serv Inc generates 0.66x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Pharma-Bio Serv Inc is currently not profitable relative to its asset base.
Pharma-Bio Serv Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 7.70 | 8.32 | 5.23 |
| Quick Ratio | 7.70 | 8.32 | 5.23 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $11.65 Million | $ 13.81 Million | $ 23.40 Million |
Pharma-Bio Serv Inc - Advanced Valuation Insights
This section examines the relationship between Pharma-Bio Serv Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.14 |
| Latest Market Cap to Assets Ratio | 0.29 |
| Asset Growth Rate (YoY) | -16.2% |
| Total Assets | $13.65 Million |
| Market Capitalization | $4.02 Million USD |
Valuation Analysis
Below Book Valuation: The market values Pharma-Bio Serv Inc's assets below their book value (0.29 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Pharma-Bio Serv Inc's assets decreased by 16.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Pharma-Bio Serv Inc (2007–2025)
The table below shows the annual total assets of Pharma-Bio Serv Inc from 2007 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-10-31 | $13.65 Million | -16.20% |
| 2024-10-31 | $16.29 Million | -18.14% |
| 2023-10-31 | $19.90 Million | -3.63% |
| 2022-10-31 | $20.65 Million | -13.67% |
| 2021-10-31 | $23.92 Million | -20.05% |
| 2020-10-31 | $29.92 Million | +12.34% |
| 2019-10-31 | $26.63 Million | +4.94% |
| 2018-10-31 | $25.38 Million | +13.55% |
| 2017-10-31 | $22.35 Million | -6.87% |
| 2016-10-31 | $24.00 Million | -0.58% |
| 2015-10-31 | $24.14 Million | +4.00% |
| 2014-10-31 | $23.21 Million | +9.06% |
| 2013-10-31 | $21.28 Million | +35.25% |
| 2012-10-31 | $15.73 Million | +45.00% |
| 2011-10-31 | $10.85 Million | +65.48% |
| 2010-10-31 | $6.56 Million | +8.90% |
| 2009-10-31 | $6.02 Million | -25.76% |
| 2008-10-31 | $8.11 Million | -15.17% |
| 2007-10-31 | $9.56 Million | -- |